Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Naturalistic, Multisite, Observational Study of Rotigotine Transdermal Patch and Other Currently Prescribed Therapies in Patients With Idiopathic Parkinson's Disease

NCT00599339 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00599339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00599339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Naturalistic, Multisite, Observational Study of Rotigotine Transdermal Patch and Other Currently Prescribed Therapies in Patients With Idiopathic Parkinson's Disease
Lead sponsor
UCB Pharma
Phase
Observational
Overall status
Completed
Start date
June 30, 2006
Completion date
April 30, 2014
Enrollment
2,195 (actual)
Sites
211

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic parkinson disease